drugset / Trial / NCT02605772
Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
To investigate the Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes,100 patients with T2DM will be enrolled in this study.They will randomly be assigned to Acarbose+Saxagliptin or Metformin+Saxagliptin group.HbA1c，fasting and postprandial C-peptide will be observed before and after the interventions.
Timeline
- Start
- 2015-12
- Primary completion
- 2016-11
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acarbose | Unknown | 100 mg | — |
| Subject | Metformin | Small molecule | 0.5 g | — |
| Subject | SAXAGLIPTIN ANHYDROUS | Small molecule | 5 mg | — |